Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9921-9928
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9921
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9921
Table 1 Relevant laboratory examination reports on admission
| Parameter | Result | Normal range |
| Liver and kidney function | ||
| Alanine aminotransferase | 1442.8 | 7-40 U/L |
| Aspartate aminotransferase | 1565 | 13-35 U/L |
| Alkaline Phosphatase | 217 | 50-135 U/L |
| γ-glutamyl transferase | 183.2 | 7-45 U/L |
| Total bilirubin | 110 | 3.4-22 μmol/L |
| Direct bilirubin | 91.1 | 1.7-10.3 μmol/L |
| Albumin | 36.9 | 40-55 g/L |
| Globulin | 22.3 | 20-40 g/L |
| Serum creatinine | 43.6 | 35-80 μmol/L |
| Serum urea | 4.74 | 2.9-8.2 mmol/L |
| Serum lipids | ||
| Total cholesterol | 3.67 | 3.4-5.8 mmol/L |
| Low-density lipoprotein cholesterol | 0.6 | 0.78-2 mmol/L |
| High-density lipoprotein cholesterol | 1.91 | 0-3.7 mmol/L |
| Triglycerides | 1.88 | 0.56-1.7 mmol/L |
| Coagulation function | ||
| Prothrombin Time | 13.7 | 11.0-15.0 sec |
| Prothrombin activity | 86.56 | 75%-160% |
| International normalized ratio | 1.02 | 0.8-1.5 |
| Complete blood count | ||
| Leukocyte | 1.17 | 4.5-10 × 109 cells/L |
| Neutrophils | 0.02 | 1.8-6.3 × 109 cells/L |
| Eosinophils | 0 | 0.02-0.52 × 109 cells/L |
| Basophils | 0 | 0-0.06 × 109 cells/L |
| Lymphocytes | 0.98 | 1.1-3.2 × 109 cells/L |
| Monocytes | 0.17 | 0.1-0.6 × 109 cells/L |
| Erythrocyte | 4.07 | 3.8-5.1 × 1012 cells/L |
| Platelet | 159 | 125-350 × 109 cells/L |
| Inflammatory markers | ||
| C-reactive protein | 10.28 | 0-5 mg/L |
| Procalcitonin | 0.192 | 0-0.05 ng/mL |
| Screening for causes of acute liver injury | ||
| Autoimmune liver diseases | ||
| Immunoglobulin A | 1.4 | 0.72-4.29 g/L |
| Immunoglobulin G | 13.3 | 8-17 g/L |
| Immunoglobulin G4 | 0.427 | 0.05-1.54 g/L |
| Immunoglobulin M | 1.2 | 0.29-3.44 g/L |
| Anti-nuclear antibody | Negative | |
| Anti-smooth muscle antibody | Negative | |
| Anti-liver kidney microsome-1 | Negative | |
| Anti-soluble liver antigen/liver pancreas antigen | Negative | |
| Anti-liver cytosol-1 | Negative | |
| Anti-centromere antibody | Negative | |
| Anti-Mitochondrial-M2 antibody | Negative | |
| Anti-gp210 antibodies | Negative | |
| Anti-Sp100 antibodies | Negative | |
| Virology test | ||
| Hepatitis A IgM | Negative | |
| Hepatitis B surface antigen | Negative | |
| Hepatitis B core antibody IgM | Negative | |
| Hepatitis C antibody | Negative | |
| Hepatitis E IgM | Negative | |
| Anti-CMV IgM | Negative | |
| Anti-EBV viral capsid antigen IgM | Negative | |
| Anti-EBV early antigen IgM | Negative | |
| COVID-19 RNA | Negative | |
| HBV DNA | < 100 | < 100 IU/mL |
| Thyroid function | ||
| Thyroid-stimulating hormone | 0.8 | 0.56-5.91 uIU/mL |
| Free triiodothyronine | 4.4 | 3.53-7.37 pmol/L |
| Free Thyroxine | 14.68 | 7.98-16.02 pmol/L |
| Other | ||
| Ceruloplasmin | 0.36 | 0.16-0.45 g/L |
| Alpha-fetoprotein | 2.9 | 0.0-9.0 ng/mL |
Table 2 Histological description of bone marrow aspiration at admission (total number of 200 nucleated cells)
| Cell type | % | Reference value range |
| Myeloblasts | 1.5 | 0.31-0.97 |
| Promyelocytes | 1.5 | 1.51-1.63 |
| Neutrophilic myelocytes | 2.5 | 4.45-8.53 |
| Neutrophilic metamyelocytes | 2 | 5.93-9.87 |
| Neutrophilic stab granulocytes | 0 | 20.22-27.22 |
| Neutrophilic segmented granulocytes | 0 | 6.52-12.36 |
| Eosinophils | 0 | 0.15-0.61 |
| Basophils | 0 | 0.00-0.07 |
| Pronormoblasts | 0.5 | 0.27-0.87 |
| Early erythroblasts | 0.5 | 0.51-1.33 |
| Polychromatic normoblasts | 12.5 | 5.5-9.32 |
| Orthochromatic normoblasts | 33.5 | 8.39-13.11 |
| Lymphocytes | 42.5 | 15.71-29.82 |
| Monocytes | 2.5 | 2.12-3.88 |
| Plasmacytes | 0.5 | 0.29-1.13 |
| Total | 100 | |
| Myeloid:erythroid ratio | 0.16 | 2-4:1 |
- Citation: Shao YL, Ma CM, Wu JM, Guo FC, Zhang SC. Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report. World J Clin Cases 2022; 10(27): 9921-9928
- URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9921.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9921
